Grifols, S.A. (GRFS)
NASDAQ: GRFS · IEX Real-Time Price · USD
6.52
+0.24 (3.82%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Grifols Revenue
In the year 2023, Grifols had annual revenue of $7.32B with 13.54% growth.
Revenue (ttm)
$7.32B
Revenue Growth
+13.54%
P/S Ratio
0.73
Revenue / Employee
$308,565
Employees
23,737
Market Cap
5.33B USD
Revenue Chart
* The company reports in EUR currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.32B | 873.39M | 13.54% |
Dec 31, 2022 | 6.45B | 845.21M | 15.08% |
Dec 31, 2021 | 5.61B | -906.43M | -13.92% |
Dec 31, 2020 | 6.51B | 783.38M | 13.67% |
Dec 31, 2019 | 5.73B | 571.71M | 11.09% |
Dec 31, 2018 | 5.16B | -24.74M | -0.48% |
Dec 31, 2017 | 5.18B | 919.81M | 21.58% |
Dec 31, 2016 | 4.26B | -11.34M | -0.27% |
Dec 31, 2015 | 4.27B | 213.59M | 5.26% |
Dec 31, 2014 | 4.06B | 289.49M | 7.68% |
Dec 31, 2013 | 3.77B | 313.07M | 9.06% |
Dec 31, 2012 | 3.46B | 1.13B | 48.73% |
Dec 31, 2011 | 2.32B | 999.88M | 75.49% |
Dec 31, 2010 | 1.32B | 15.20M | 1.16% |
Dec 31, 2009 | 1.31B | 174.54M | 15.38% |
Dec 31, 2008 | 1.13B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Organon & Co. | 6.35B |
Bausch + Lomb | 4.31B |
DENTSPLY SIRONA | 3.94B |
Lantheus Holdings | 1.37B |
Tempus AI | 562.02M |
Glaukos | 326.43M |
Krystal Biotech | 95.95M |
GRFS News
- 10 hours ago - Probe Into Claims Against Grifols SA Initiated By The Schall Law Firm And Impacted Investors Are Encouraged To Start Contact - Accesswire
- 11 hours ago - Unit of Grifols shareholder Scranton reaches debt refinancing deal - Reuters
- 1 day ago - Grifols' Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years - GlobeNewsWire
- 4 days ago - The Schall Law Firm Begins Probe Into Claims Against Grifols SA And Urges Affected Investors To Initiate Contact - Accesswire
- 6 days ago - The Schall Law Firm Initiates Investigation Into Allegations Against Grifols SA And Encourages Impacted Investors To Establish Communication - Accesswire
- 9 days ago - The Schall Law Firm Begins Probe Into Claims Against Grifols SA And Urges Affected Investors To Make Contact - Accesswire
- 10 days ago - The Schall Law Firm Initiates Investigation Into Allegations Against Grifols SA And Encourages Impacted Investors To Reach Out - Accesswire
- 13 days ago - Claims Against Grifols SA The Schall Law Firm Begins Probe And Urges Affected Investors To Make Contact - Accesswire